DA
DCF Advisers Portfolio holdings
AUM
$208M
This Quarter Return
+24.89%
1 Year Return
+21.52%
3 Year Return
+75.42%
5 Year Return
+129.34%
10 Year Return
–
AUM
$146M
AUM Growth
+$146M
(+27%)
Cap. Flow
+$414K
Cap. Flow
% of AUM
0.28%
Top 10 Holdings %
Top 10 Hldgs %
51.94%
Holding
68
New
4
Increased
17
Reduced
24
Closed
7
Top Buys
| 1 |
Xencor
XNCR
|
$3.45M |
| 2 |
Esperion Therapeutics
ESPR
|
$1.36M |
| 3 |
Verizon
VZ
|
$965K |
| 4 |
SPDR Gold Trust
GLD
|
$837K |
| 5 |
Target
TGT
|
$600K |
Top Sells
| 1 |
Bristol-Myers Squibb
BMY
|
$1.12M |
| 2 |
XYZ
Block, Inc.
XYZ
|
$1.05M |
| 3 |
VanEck Gold Miners ETF
GDX
|
$825K |
| 4 |
Berkshire Hathaway Class B
BRK.B
|
$625K |
| 5 |
General Motors
GM
|
$623K |
Sector Composition
| 1 | Healthcare | 45.9% |
| 2 | Technology | 16.8% |
| 3 | Communication Services | 11.17% |
| 4 | Financials | 6.39% |
| 5 | Consumer Discretionary | 1.99% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
VanEck Junior Gold Miners ETF
GDXJ
$6.6B
| $2.11M | 1.18% | 42,500 +7,500 | +21% | +$372K |
|
|
27
Berkshire Hathaway Class B
BRK.B
$1.09T
| $2.05M | 1.15% | 11,500 -3,500 | -23% | -$625K |
|
28
Lowe's Companies
LOW
$145B
| $1.69M | 0.95% | 12,500 +1,500 | +14% | +$203K |
|
|
ALXN
29
DELISTED
Alexion Pharmaceuticals Inc
ALXN
| $1.46M | 0.82% | 13,000 +4,000 | +44% | +$449K |
|
|
AMRN
30
Amarin Corp
AMRN
$311M
| $1.34M | 0.75% | 193,250 -10,750 | -5% | -$74.4K |
|
31
Cisco
CSCO
$274B
| $1.17M | 0.65% | 25,000 -7,500 | -23% | -$350K |
|
32
Box
BOX
$4.73B
| $1.04M | 0.58% | 50,000 +10,000 | +25% | +$208K |
|
|
ARNA
33
DELISTED
Arena Pharmaceuticals Inc
ARNA
| $1.01M | 0.56% | 16,000 -500 | -3% | -$31.5K |
|
34
Nektar Therapeutics
NKTR
$568M
| $996K | 0.56% | 43,000 | – | – |
|
35
Nokia
NOK
$23.1B
| $946K | 0.53% | 215,000 +65,000 | +43% | +$286K |
|
36
IBM
IBM
$227B
| $906K | 0.51% | 7,500 | – | – |
|
37
Intel
INTC
$107B
| $897K | 0.5% | 15,000 +5,000 | +50% | +$299K |
|
|
STEW
38
SRH Total Return Fund
STEW
$1.79B
| $835K | 0.47% | 88,683 +29,900 | +51% | +$282K |
|
39
Gen Digital
GEN
$18.6B
| $793K | 0.44% | 40,000 | – | – |
|
40
Aptiv
APTV
$17.3B
| $779K | 0.44% | 10,000 -2,500 | -20% | -$195K |
|
41
Apple
AAPL
$3.45T
| $730K | 0.41% | 2,000 -500 | -20% | -$183K |
|
42
Sangamo Therapeutics
SGMO
$157M
| $631K | 0.35% | 70,400 +16,500 | +31% | +$148K |
|
|
43
Target
TGT
$43.6B
| $600K | 0.34% | +5,000 | New | +$600K |
|
|
WBA
44
DELISTED
Walgreens Boots Alliance
WBA
| $530K | 0.3% | 12,500 -3,000 | -19% | -$127K |
|
45
Microsoft
MSFT
$3.77T
| $509K | 0.28% | 2,500 | – | – |
|
46
Qualcomm
QCOM
$173B
| $456K | 0.26% | 5,000 | – | – |
|
|
TBHC
47
The Brand House Collective, Inc. Common Stock
TBHC
$33.7M
| $446K | 0.25% | 164,693 +16,500 | +11% | +$44.7K |
|
|
APTX
48
DELISTED
Aptinyx Inc. Common Stock
APTX
| $445K | 0.25% | 106,800 +1,000 | +0.9% | +$4.17K |
|
49
Matinas BioPharma
MTNB
$10.1M
| $436K | 0.24% | 563,795 -56,205 | -9% | -$43.5K |
|
50
Genmab
GMAB
$15.3B
| $424K | 0.24% | +12,500 | New | +$424K |
|